Last 44 quarters of trend data · Healthcare · Medical Imaging & Radiation
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.36 | — | — | — | — | — | — | — | 18.40 | 19.52 | 13.50 | 6.79 | 2.27 | — | — | — | 10.91 | 28.48 | 9.14 | 2.61 | 5.64 |
| — | — | — | — | — | — | — | — | +711.0% | — | — | — | -79.2% | — | — | — | +93.4% | -68.4% | — | — | -64.9% | |
| P/S Ratio | 2.28 | 2.05 | 5.43 | 4.83 | 3.29 | 1.86 | 2.64 | 2.32 | 2.18 | 2.68 | 2.36 | 1.45 | 0.76 | 2.89 | 2.83 | 6.20 | 2.35 | 5.77 | 2.64 | 4.07 | 2.30 |
| — | +10.2% | +105.3% | +108.2% | +51.1% | -30.6% | +12.2% | +59.5% | +184.9% | -7.2% | -16.7% | -76.5% | -67.4% | -49.9% | +6.9% | +52.2% | +2.0% | +114.7% | -9.5% | -20.7% | -26.2% | |
| P/B Ratio | 0.78 | 1.39 | 1.35 | 1.44 | 1.35 | 1.00 | 1.49 | 1.46 | 2.04 | 1.75 | 1.65 | 1.21 | 0.79 | 1.01 | 1.11 | 1.83 | 2.56 | 4.41 | 2.84 | 3.97 | 4.61 |
| — | +38.7% | -9.2% | -1.4% | -33.7% | -42.8% | -9.7% | +20.5% | +159.2% | +73.3% | +47.9% | -33.7% | -69.3% | -77.1% | -60.8% | -53.9% | -44.5% | +53.1% | -9.5% | +28.6% | +55.9% | |
| P/FCF | — | — | — | — | — | 5.59 | 6.26 | — | — | 6.55 | 5.15 | — | 3.60 | 26.14 | 17.95 | — | — | 14.19 | 17.25 | 13.86 | — |
| — | — | — | — | — | -14.6% | +21.6% | — | — | -74.9% | -71.3% | — | — | +84.2% | +4.0% | — | — | +19.5% | +47.0% | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 12.41 | 11.41 | 8.35 | 4.00 | 0.71 | — | — | — | 5.80 | 19.17 | 5.12 | 8.50 | 4.83 |
| — | — | — | — | — | — | — | — | +1659.1% | — | — | — | -87.8% | — | — | — | +20.0% | -43.1% | — | — | -80.8% | |
| EV / EBIT | — | — | — | — | — | 13.07 | — | — | 11.80 | 10.27 | 7.85 | 3.87 | 0.69 | — | — | — | 5.59 | 18.80 | 5.18 | 8.70 | 4.96 |
| — | — | — | — | — | +27.3% | — | — | +1608.6% | — | — | — | -87.6% | — | — | — | +12.6% | -66.2% | — | — | -59.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 54.8% | 33.6% | 29.2% | 38.4% | 39.4% | 39.7% | 52.2% | 54.4% | 59.3% | 58.7% | 62.5% | 62.3% | 51.0% | 57.9% | 47.5% | 63.7% | 65.2% | 68.3% | 69.2% | 68.0% |
| — | +39.2% | -15.4% | -44.0% | -29.3% | -33.5% | -32.4% | -16.5% | -12.7% | +16.2% | +1.5% | +31.5% | -2.2% | -21.7% | -15.4% | -31.3% | -6.3% | +12.5% | +10.8% | +33.9% | +7.3% | |
| Operating Margin | -37.5% | -27.0% | -138.9% | -128.4% | -63.8% | -37.3% | -26.6% | -31.7% | 13.2% | 16.9% | 21.5% | 27.1% | 44.4% | -48.6% | -24.9% | -86.1% | 31.8% | 24.0% | 37.8% | 38.0% | 40.8% |
| — | +27.6% | -422.8% | -304.9% | -582.7% | -320.6% | -223.8% | -217.1% | -70.2% | +134.8% | +186.2% | +131.5% | +39.4% | -302.7% | -165.8% | -326.5% | -22.0% | +579.6% | +835.2% | +204.7% | +708.4% | |
| Net Margin | -28.1% | -24.9% | -382.1% | -77.4% | -64.1% | -13.7% | -14.2% | -30.8% | 11.8% | 13.7% | 17.4% | 21.3% | 33.5% | -37.2% | -8.4% | -55.5% | 21.6% | 20.3% | 29.2% | 155.4% | 40.8% |
| — | -81.8% | -2595.0% | -151.0% | -641.9% | -199.7% | -181.2% | -244.5% | -64.7% | +136.9% | +307.9% | +138.4% | +55.2% | -283.4% | -128.8% | -135.7% | -47.1% | +475.2% | +666.9% | +527.8% | +104.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.9% | -4.1% | -21.2% | -5.6% | -6.4% | -1.8% | -2.0% | -4.7% | 2.8% | 2.3% | 3.1% | 4.5% | 9.0% | -3.2% | -0.8% | -4.0% | 5.9% | 4.0% | 8.1% | 46.9% | 22.8% |
| — | -126.1% | -976.0% | -18.7% | -326.9% | -180.5% | -163.7% | -203.9% | -68.8% | +170.9% | +476.2% | +213.3% | +51.6% | -180.7% | -110.2% | -108.6% | -73.9% | +315.4% | +686.8% | +982.1% | +369.4% | |
| ROA | -13.4% | -3.6% | -18.9% | -5.0% | -5.7% | -1.6% | -1.7% | -4.2% | 2.5% | 2.1% | 2.8% | 4.1% | 8.1% | -2.8% | -0.7% | -3.4% | 5.1% | 3.3% | 6.4% | 37.3% | 18.4% |
| — | -126.7% | -982.4% | -19.5% | -324.5% | -178.2% | -162.4% | -202.6% | -68.6% | +172.8% | +487.4% | +219.1% | +59.1% | -185.9% | -111.3% | -109.2% | -72.4% | +338.9% | +705.3% | +1011.0% | +402.9% | |
| ROIC | -25.3% | -5.4% | -9.6% | -12.0% | -8.8% | -6.7% | -4.5% | -5.8% | 3.9% | 3.4% | 4.1% | 6.8% | 16.3% | -5.5% | -3.1% | -8.6% | 18.3% | 14.0% | 29.5% | 26.2% | 49.0% |
| — | +18.8% | -114.7% | -109.2% | -325.1% | -298.8% | -208.2% | -184.6% | -76.1% | +161.1% | +234.1% | +179.5% | -11.1% | -139.1% | -110.5% | -132.7% | -62.6% | +413.7% | +1098.5% | +350.7% | +1736.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 |
| — | -24.8% | -18.6% | -27.5% | +31.1% | -13.3% | -13.4% | -15.1% | -32.7% | -35.5% | -30.9% | -30.9% | -24.4% | -17.6% | -23.4% | -22.9% | +145.3% | +35.1% | -55.2% | -55.6% | -86.5% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 0.32 | 0.41 | 0.34 | 0.25 | 0.14 | — | — | — | 0.24 | 0.48 | 0.24 | 0.29 | 0.04 |
| — | — | — | — | — | — | — | — | +134.9% | — | — | — | -42.6% | — | — | — | +482.9% | -55.5% | — | — | -98.5% | |
| Current Ratio | 9.72 | 6.77 | 8.71 | 7.27 | 9.72 | 7.38 | 8.14 | 8.06 | 9.64 | 10.52 | 11.63 | 9.85 | 11.76 | 8.77 | 9.13 | 7.96 | 6.92 | 7.83 | 5.01 | 4.72 | 5.24 |
| — | -8.3% | +6.9% | -9.8% | +0.8% | -29.8% | -30.0% | -18.2% | -18.0% | +20.0% | +27.5% | +23.8% | +70.0% | +12.0% | +82.3% | +68.5% | +32.0% | +52.7% | +5.8% | -7.5% | +1.1% | |
| Quick Ratio | 6.63 | 3.25 | 4.44 | 4.45 | 6.63 | 5.46 | 6.21 | 6.58 | 7.93 | 8.22 | 8.91 | 7.16 | 8.94 | 6.24 | 7.18 | 6.93 | 6.46 | 7.47 | 4.84 | 4.50 | 4.94 |
| — | -40.5% | -28.5% | -32.4% | -16.3% | -33.6% | -30.3% | -8.1% | -11.4% | +31.7% | +24.1% | +3.3% | +38.4% | -16.4% | +48.2% | +54.1% | +30.7% | +59.0% | +17.4% | +7.3% | +15.8% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2280.00 | 4595.00 | — | 5319.00 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 44 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SRTS stock.
Sensus Healthcare, Inc.'s current P/E is -2.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Sensus Healthcare, Inc.'s current operating margin is -37.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sensus Healthcare, Inc.'s business trajectory between earnings reports.